
"Upstream" with Erik Torenberg
E78: Fertility, Healthy Humans, and Ending Genetic Disease w/ Noor Siddiqui, CEO of Orchid
Sep 19, 2024
In this insightful discussion, Noor Siddiqui, CEO of Orchid, delves into revolutionary advancements in reproductive technology, particularly the first whole genome embryo screening. She highlights the significant journey of improving genomic sequencing accuracy and how these innovations can drastically reduce genetic diseases. Noor addresses the evolving societal views on IVF and reproductive tech, navigating stigmas and ethical concerns while outlining a future where parenting norms may transform. Her passion for making fertility solutions accessible shines through as she shares Orchid's mission.
01:11:28
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Orchid's whole genome embryo screening offers unprecedented genetic insight, allowing parents to significantly reduce the risk of severe diseases in their children.
- The incorporation of polygenic risk scores enables parents to make informed decisions regarding embryo selection, ultimately improving health outcomes for future generations.
Deep dives
Revolutionizing Embryo Screening
The introduction of whole genome sequencing for embryos marks a significant advancement in reproductive technology. Unlike traditional methods that provide limited data, Orchid's technology allows for sequencing about 99% of the embryo's genome, compared to the less than 1% offered by previous methods. This extensive data facilitates more thorough insight into potential genetic conditions, providing parents with crucial information to prevent severe diseases. Such innovations have the potential to drastically reduce the incidence rates of various genetic disorders, making significant strides in public health.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.